Scarica l'app Stockscreener
0.00
100.00%
-2.65
Dopo l'orario di chiusura:
2.65
2.65
+
Repare Therapeutics Inc Borsa (RPTX) Ultime notizie
Repare Therapeutics announces shareholder meeting for acquisition approval - MSN
RPTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Will Repare Therapeutics Inc. stock benefit from infrastructure spendingCEO Change & Expert Curated Trade Ideas - mfd.ru
Is Repare Therapeutics Inc forming a bullish divergenceForecast Cut & Low Volatility Stock Recommendations - baoquankhu1.vn
Will Repare Therapeutics Inc. stock keep outperforming rivalsJuly 2025 Spike Watch & Risk Controlled Swing Trade Alerts - mfd.ru
[15-12G] Repare Therapeutics Inc. SEC Filing - Stock Titan
How Repare Therapeutics Inc. stock reacts to oil prices2025 Price Targets & Verified Technical Trade Signals - mfd.ru
Is Repare Therapeutics Inc. stock heavily shortedMarket Risk Summary & AI Driven Price Forecasts - mfd.ru
Why Repare Therapeutics Inc. stock could outperform in 2025July 2025 Market Mood & Safe Capital Growth Tips - mfd.ru
Is Repare Therapeutics Inc. stock a smart buy before Fed meetingEarnings Beat & Community Shared Stock Ideas - mfd.ru
Pyxis Oncology, Inc. Announces Chief Executive Officer Changes, Effective February 3, 2026 - marketscreener.com
Gilead’s Growing Oncology Role Reshapes The Investment Case For GILD - Sahm
Published on: 2026-02-02 06:19:02 - baoquankhu1.vn
Shay Capital LLC's Strategic Acquisition of Repare Therapeutics Inc Shares - GuruFocus
Repare Therapeutics completes acquisition and goes private - The Globe and Mail
Repare Therapeutics Inc. (NASDAQ:RPTX) Short Interest Up 125.3% in January - MarketBeat
Repare Announces Completion of Acquisition by XenoTherapeutics - citybiz
Repare Therapeutics Announced Transfer or Voluntary Withdrawal of Listing - TradingView
RPTX Technical Analysis & Stock Price Forecast - Intellectia AI
Repare Shareholders Approve Acquisition by XenoTherapeutics - citybiz
Repare Shareholders approve acquisition by XenoTherapeutics - Medical Buyer
Repare Therapeutics (RPTX) Shareholders Approve Acquisition by X - GuruFocus
Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc. - Investing News Network
Repare Therapeutics Shareholders Approve Acquisition by XenoTherapeutics - TipRanks
99.76% of Repare voters back takeover by nonprofit XenoTherapeutics - Stock Titan
Bank Watch: Is Repare Therapeutics Inc stock heavily shorted2025 Support & Resistance & Reliable Intraday Trade Plans - baoquankhu1.vn
Repare Therapeutics Inc. (NASDAQ:RPTX) Short Interest Update - MarketBeat
Update Report: Is Repare Therapeutics Inc stock heavily shorted2025 Market Trends & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Repare Therapeutics (NASDAQ:RPTX) Stock Price Up 0.4%Here's Why - MarketBeat
Repare Therapeutics (NASDAQ:RPTX) Stock Price Up 0.4% – Here’s Why - Defense World
Levels Update: Is Repare Therapeutics Inc. stock a top pick in earnings season2025 Sector Review & Daily Stock Trend Watchlist - Bộ Nội Vụ
Aug Opening: Will Repare Therapeutics Inc stock attract ESG investorsMarket Sentiment Summary & AI Driven Stock Price Forecasts - Bộ Nội Vụ
Insider Trends: Why Repare Therapeutics Inc. stock is in analyst buy zonePortfolio Update Report & Capital Efficient Trading Techniques - Bộ Nội Vụ
Published on: 2026-01-13 02:16:07 - baoquankhu1.vn
What catalysts could drive Repare Therapeutics Inc. stock higherTrade Exit Summary & Smart Investment Allocation Tips - Улправда
Oklahoma City NewsThe OklahomanRepare Therapeutics Inc.Common Shares (Nasdaq:RPTX) Stock Quote - FinancialContent
Is Repare Therapeutics Inc. stock a safe investment in uncertain marketsJuly 2025 Review & Risk Managed Trade Strategies - Улправда
Can Repare Therapeutics Inc. stock sustain free cash flow growthJuly 2025 Weekly Recap & Weekly Top Stock Performers List - Улправда
Will Repare Therapeutics Inc. stock benefit from commodity prices2025 Big Picture & Momentum Based Trading Signals - ulpravda.ru
Repare Therapeutics sells RP-3467 cancer program assets to Gilead for up to $30 million - MSN
Can Repare Therapeutics Inc. stock double in next 5 yearsVolatility Adjusted Trading & Learn to Trade with Real-Time Feedback - Улправда
Repare Therapeutics Inc.Common Shares (NQ: RPTX - FinancialContent
Repare Therapeutics Sells RP-3467 Cancer Program Assets to Gilead for Up to $30 Million - TipRanks
Repare Therapeutics Announces Gilead Acquisition of RP-3467 for Up to $30 Million - citybiz
PYXS,RPTX Dividends - Finviz
Repare Therapeutics announces CSO resignation and transition plan - MSN
Repare Therapeutics Sells RP-3467 Program to Gilead - The Globe and Mail
Aug Drivers: How buybacks impact Repare Therapeutics Inc stock valueMarket Movement Recap & Weekly High Return Stock Forecasts - moha.gov.vn
Bernstein reiterates Gilead Sciences stock rating, citing minimal Medicaid impact - Investing.com Nigeria
Repare Therapeutics Signs Asset Purchase Agreement With Gilead Sciences - TradingView — Track All Markets
Repare Sells Key Oncology Asset to Gilead, Lifts Expected Xeno Deal Payout - TipRanks
RPTX stock soars pre-market after Gilead agrees to acquire investigational cancer drug - MSN
Gilead to buy Repare Thera’s cancer candidate for up to $30M - MSN
Gilead Sciences to acquire Repare’s RP-3467 - Pharmaceutical Technology
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):